Immediate Impact
2 from Science/Nature 80 standout
Citing Papers
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023 Standout
Insomnia
2022 Standout
Works of Melvin Munsaka being referenced
Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus
2013
The Effects of Psychotherapy, Nefazodone, and Their Combination on Subjective Assessment of Disturbed Sleep in Chronic Depression
2003
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Melvin Munsaka | 50 | 149 | 46 | 67 | 55 | 12 | 288 | |
| Ann C Scates | 7 | 53 | 36 | 66 | 41 | 8 | 291 | |
| Masahiko Miyagi | 13 | 232 | 27 | 93 | 14 | 14 | 301 | |
| Shiho Nakayama | 10 | 122 | 17 | 49 | 70 | 16 | 324 | |
| Rebecca Thompson | 8 | 100 | 40 | 48 | 30 | 23 | 324 | |
| Armen Yerevanian | 19 | 88 | 44 | 137 | 6 | 12 | 327 | |
| Tibor Hídvégi | 17 | 134 | 17 | 44 | 19 | 26 | 323 | |
| Sunil Kumar | 33 | 31 | 14 | 69 | 15 | 15 | 247 | |
| Enrico Grassi | 51 | 38 | 19 | 59 | 15 | 21 | 304 | |
| Suwen Su | 13 | 19 | 15 | 67 | 30 | 9 | 286 | |
| Anna Girardi | 14 | 53 | 19 | 37 | 8 | 19 | 307 |
All Works
Loading papers...